Skip to main content
SpringerLink
Log in

Storage time of transfused blood and disease recurrence after colorectal cancer surgery

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

BACKGROUND: Perioperative blood transfusion and subsequent development of postoperative infectious complications may lead to poor prognosis of patients with colorectal cancer. It has been suggested that the development of postoperative infectious complications may be related to the storage time of the transfused blood. Therefore, we studied the relationship between blood storage time and the development of disease recurrence and long-term survival after colorectal cancer surgery. METHODS: Preoperative and postoperative data were prospectively recorded in 740 patients undergoing elective resection for primary colorectal cancer. None of the patients received preoperative or postoperative chemotherapy or radiation therapy. Endpoints were overall survival and disease recurrence in the subgroup of patients operated on with curative intention who also survived the first 30 days after operation. Storage of buffy-coat-depleted red cells suspended in saline, adenine, glucose, and mannitol blood for 21 days was used as cut-off point. RESULTS: Median follow-up was 6.8 years (range, 5.4 years to 7.9 years), and median overall survival was 4.6 years for 288 nontransfused patients and 3.0 years for 452 transfused patients (P=0.004). The survival of patients receiving blood exclusively stored < 21 days was 2.5 years. For patients receiving any blood stored ≥21 days, survival was 3.7 years (P=0.12). Among patients with curative resection (n=532), the hazard ratio of disease recurrence was 1.5 (95 percent CI; 1.1 to 2.2) and 1.0 (95 percent CI; 0.7 to 1.4) in the two transfused groups, respectively, compared with the nontransfused group after multivariable correction for patient age, gender, colonic/rectal tumor localization, Dukes classification, blood loss, and postoperative infectious complications. CONCLUSION: Transfusion of buffy-coat-depleted red cells suspended in saline, adenine, glucose, and mannitol blood stored for < 21 days may be an independent risk factor for development of recurrence after elective colorectal cancer surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633–8.

    PubMed  Google Scholar 

  2. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995;82:582–7.

    PubMed  Google Scholar 

  3. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 1996;101:299–308.

    Article  PubMed  Google Scholar 

  4. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187–204.

    Article  PubMed  Google Scholar 

  5. Mynster T, Dybkjaer E, Kronborg G, Nielsen HJ. Immunomodulating effect of blood transfusion. Is storage-time important? Vox Sang 1998;74:176–81.

    Article  PubMed  Google Scholar 

  6. Mynster T, Dybkjær E, Reimert CM,et al. Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation. Inflamm Res 1999;48:363–8.

    Article  PubMed  Google Scholar 

  7. Nielsen HJ. Clinical impact of bioactive substances in blood components for perioperative transfusion. Implications for leukocyte filtration. Infusionsther Transfusionsmed 1998;25:296–304.

    Article  Google Scholar 

  8. Hyllner M, Arnestad JP, Bengtson JP, Rydberg L, Bengtsson A. Complement activation during storage of whole blood, red cells, plasma, and buffy coat. Transfusion 1997;37:264–8.

    Article  PubMed  Google Scholar 

  9. Vamvakas E, Carven JH. Transfusion and postoperative pneumonia in coronary artery by-pass surgery: effect of the length of storage of transfused red cells. Transfusion 1999;39:701–10.

    Article  PubMed  Google Scholar 

  10. Mynster T, Nielsen HJ, The RANX05 Colorectal Cancer Study Group. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Scand J Gastroenterol 2000;35:212–7.

    Article  PubMed  Google Scholar 

  11. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 1997;44:1256–61.

    PubMed  Google Scholar 

  12. Mynster T, Nielsen HJ. The effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Br J Surg 2000;87:1553–62.

    Article  PubMed  Google Scholar 

  13. Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion: is blood storage time important? Dis Colon Rectum 1990;33:127–30.

    Article  PubMed  Google Scholar 

  14. Lawrance RJ, Cooper AJ, Loizidou M, Alexander P, Taylor I. Blood transfusion and recurrence of colorectal cancer: the role of platelet derived growth factors. Br J Surg 1990;77:1106–9.

    PubMed  Google Scholar 

  15. Nielsen HJ, McArdle CS, Moesgaard F. The effect of ranitidine on postoperative infectious complications after elective colorectal surgery. GI Cancer 1999;3:87–95.

    Google Scholar 

  16. Nielsen HJ, McArdle CS, Moesgaard F. The effect of ranitidine on long term survival in primary colorectal cancer. GI Cancer 1998;2:227–33.

    Google Scholar 

  17. Edna T-H, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998;41:451–9

    Article  PubMed  Google Scholar 

  18. Busch ORC, Hop WCJ, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Ann Surg 1994;220:791–7.

    PubMed  Google Scholar 

  19. Nielsen HJ. The effect of histamine type-2 receptor antagonists on posttraumatic immune competence. Dan Med Bull 1995;42:162–74.

    PubMed  Google Scholar 

  20. Zallen G, Offner PJ, Moore EE,et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999;178:570–2.

    Article  PubMed  Google Scholar 

  21. Schechter GP, Soehnlen F, Mcfarland W. Lymphocyte response to blood transfusion in man. N Engl J Med 1972;287:1169–73.

    PubMed  Google Scholar 

  22. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999;116:1233–9.

    Article  PubMed  Google Scholar 

  23. Lee T-H, Donegan E, Slichter S, Busch MP. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 1995;85:1207–14.

    PubMed  Google Scholar 

  24. Lee T-H, Paglieroni T, Ohto H, Holland PV, Busch MP. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-term microchimerism in severe trauma patients. Blood 1999;93:3127–39.

    PubMed  Google Scholar 

  25. Dippold W, Meyer zum Büschenfelde KH. Proliferation of gastrointestinal carcinoma cells by T lymphocyte factors Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor. Immunol Res 1991;10:258–60.

    PubMed  Google Scholar 

  26. Lahm H, Petral-Malec D, Yilmaz-Ceyhan A,et al. Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factorβ1. Eur J Cancer 1992;28A:1894–9.

    Article  PubMed  Google Scholar 

  27. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000;12:78–85.

    Article  PubMed  Google Scholar 

  28. Chen RL, Reynolds P, Seeger RC. Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating. Cancer Immunol Immunother 2000;48:603–12.

    Article  PubMed  Google Scholar 

  29. Pellegrini P, Berghella AM, Del Beato T, Cicia S, Adorno D, Casciani CU. Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother 1996;42:1–8.

    Article  PubMed  Google Scholar 

  30. O'Hara RJ, Greenman J, Macdonald AW,et al. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res 1998;4:1943–8.

    PubMed  Google Scholar 

  31. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994;84:344–8.

    PubMed  Google Scholar 

  32. Frabetti F, Musiana D, Marini M,et al. White cell apoptosis in packed red cells. Transfusion 1998;38:1082–9.

    Article  PubMed  Google Scholar 

  33. Nielsen HJ, Reimert CM, Pedersen AN,et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996;36:960–5.

    Article  PubMed  Google Scholar 

  34. Nielsen HJ, Hansen U, Christensen IJ,et al. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999;189:487–95.

    Article  PubMed  Google Scholar 

  35. Iwasaki K, Turisu M, Fujimura T. Malignant tumor and eosinophils. Prognostic significance in gastric cancer. Cancer 1986;58:1321–7.

    PubMed  Google Scholar 

  36. Huland E, Huland H. Tumour-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells. J Cancer Res Clin Oncol 1992;118:463–7.

    Article  PubMed  Google Scholar 

  37. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685–9.

    Article  PubMed  Google Scholar 

  38. Schott A, Vogel I, Krueger U,et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;227:372–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark

    Tommie Mynster M.D. & Hans Jørgen Nielsen M.D., D.M.Sc.

Authors
  1. Tommie Mynster M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Jørgen Nielsen M.D., D.M.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

the Danish RANX05 Colorectal Cancer Study Group

About this article

Cite this article

Mynster, T., Nielsen, H.J. & the Danish RANX05 Colorectal Cancer Study Group. Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum 44, 955–964 (2001). https://doi.org/10.1007/BF02235483

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02235483

Key words

Search

Navigation